Thermo Fisher Scientific announced that its board of directors has authorized the repurchase of $4B of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on TMO: